# A Randomized Phase III Study of Palliative Radiation of Advanced Central Tumors With Intentional Avoidance of the Esophagus

> **NCT02752126** · NA · COMPLETED · sponsor: **London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's** · enrollment: 90 (actual)

## Conditions studied

- Non-Small Cell Lung Cancer

## Interventions

- **RADIATION:** Conventional radiotherapy
- **RADIATION:** Esophageal-Sparing Intensity-Modulated Radiotherapy

## Key facts

- **NCT ID:** NCT02752126
- **Lead sponsor:** London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06
- **Primary completion:** 2020-08-01
- **Final completion:** 2020-09-01
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2021-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02752126

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02752126, "A Randomized Phase III Study of Palliative Radiation of Advanced Central Tumors With Intentional Avoidance of the Esophagus". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02752126. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
